Notable Analyst Rating Changes 2/2: PFE, ESRX, CLX, AKAM Upgraded; F, NYX, ETFC, WU Downgraded
Tweet Send to a Friend
UPGRADES:
Credit Suisse upgrades Pfizer (NYSE: PFE) from Neutral to Outperform, citing merits of the Wyeth deal.
Goldman Sachs upgrades Express Scripts ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse upgrades Pfizer (NYSE: PFE) from Neutral to Outperform, citing merits of the Wyeth deal.
Goldman Sachs upgrades Express Scripts ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
